Clinical Trials Directory

Early Detection of Neuropathy and Cognitive Impairment Following Treatment for Haematological Malignancies

Treatment of Malignant Peritoneal Mesothelioma (MESOTIP)

Radiation Therapy in Combination With Durvalumab for People With Pancreatic Cancer

A-SPIRE Heart Failure: Utilizing Health Tags to Identify Patients at Risk for Hospital Readmissions

Pembrolizumab Every 12 Weeks Versus Every 3 Weeks in Treating Patients With Non-small Cell Lung Cancer

Leucovorin for the Treatment of Language Impairment in Children With Autism Spectrum Disorder

Testing the Addition of the Drug Atezolizumab to the Usual Radiation Treatment for Patients With Early Non-small Cell Lung Cancer

The Person-centered Evolution of Radiotherapy Services in Ontario Study

A Prospective, Non-interventional, Multinational, Observational Study With Isatuximab in Patients With Relapsed and/or Refractory Multiple Myeloma (RRMM)

Primary Progressive Multiple Sclerosis (PPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (PERSEUS)

Early Protein Supplementation in Extremely Preterm Infants Fed Human Milk

Recurrent Hypoglycemia in Type 1 Diabetes (Aim 2)

A Study With Jaktinib Hydrochloride Cream Applied Topically to Subjects With Alopecia Areata

Viral Specific T-Lymphocytes to Treat Adenovirus or CMV

Acupuncture for the Management of Postoperative Pain in Patients With Pancreatic or Colorectal Cancer Undergoing Surgery

Short-term Fasting Prior to PD-1/PD-L1 Inhibitor Therapy for of Advanced or Metastatic Skin Malignancy

The Revitalize Study in Older Adults at Risk for Alzheimer's Disease

Oslo Footballplayers Iron Supplementation and Training (FIT) Study

Short-Course Chemoradiotherapy Followed by Chemotherapy for the Treatment of Resectable Gastric Adenocarcinoma

Characteristics in Post Covid-19 Patients

PANDORA: Delirium Prevention After Cardiac Surgery Using IV Acetaminophen to Prevent Postoperative Delirium in Older Cardiac Surgical Patients

A Phase III Clinical Trial of AK105 Injection Combined With Anlotinib Hydrochloride Capsules Versus Sorafenib in Subjects With Advanced Hepatocellular Carcinoma (HCC)

Camrelizumab in Combination With Neoadjuvant Chemotherapy for Resectable Thoracic Esophageal Squamous Cell Carcinoma

Mechanisms of Hypoglycemia in Patients Without Diabetes

HPV Vaccine PRGN-2009 Alone or in Combination With Anti-PDL1/TGF-Beta Trap (M7824) in Subjects With HPV Associated Cancers

Restylane Refyne for Correction of Horizontal Neck Rhytides

A Multicenter, Randomized Study in Participants With Diabetic Retinopathy Without Center-involved Diabetic Macular Edema To Evaluate the Efficacy, Safety, and Pharmacokinetics of Ranibizumab Delivered Via the Port Delivery System Relative to the Comparator Arm

Determining Optimal Treatment Intensity for Children With Language Impairment

FIT Study (Functional Outcomes In Trauma Study)

Study of FURMONERTINIB in Patients With NSCLC Having Exon 20 Insertion Mutation

CFI-400945 and Durvalumab in Patients With Advanced Triple Negative Breast Cancer

A Study To Evaluate The Efficacy And Safety Of Obinutuzumab In Patients With ISN/RPS 2003 Class III Or IV Lupus Nephritis

Promoting Informed Choice for Breast Cancer Screening

Brachytherapy With Durvalumab or Tremelimumab for the Treatment of Patients With Platinum-Resistant, Refractory, Recurrent, or Metastatic Gynecological Malignancies

CPAP in AF Patients With OSA

Decision Aid for the Improvement of Decision-Making in Patients With Non-small Cell Lung Cancer

Acalabrutinib for the Treatment of Ibrutinib-Intolerant Mantle Cell Lymphoma

Neurotoxicity Prophylaxis With Intrathecal Dexamethasone and Simvastatin Post Axi-Cel

Treating Parents with ADHD and Their Young Children Via Telehealth: a Hybrid Type I Effectiveness-Implementation Trial

Dosimetry, Safety and Potential Benefit of 177Lu-PSMA-617 Prior to Prostatectomy

A Phase II Trial of PD-L1 Therapy Combined With Anti-VEGF Therapy in Unresectable or Metastatic Melanoma

Testing the Combination of XL184 (Cabozantinib), Nivolumab, and Ipilimumab for Poorly Differentiated Neuroendocrine Tumors

Lenvatinib (E7080/MK-7902) in Combination With Pembrolizumab (MK-3475) vs. Standard Chemotherapy and Lenvatinib Monotherapy in Participants With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma That Progressed After Platinum Therapy and Immunotherapy (MK-7902-009/E7080-G000-228/LEAP-009)

Cirmtuzumab Consolidation for Treatment of Patients With Detectable CLL on Venetoclax

Long-term Effectiveness, Safety, and Performance of the Evoke Closed-Loop SCS System to Treat Patients With Chronic Pain of the Trunk and/or Limbs

Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With COVID-19

Mycophenolate Mofetil Combined With Radiation Therapy in Glioblastoma

Open-label Extension of the HOPE-2 Trial

A Study to Evaluate MEDI5752 and Axitinib in Subjects With Advanced Renal Cell Carcinoma

NICU Antibiotics and Outcomes Trial